Home | Business News | CBJ Newsmakers | Vielight Commences Pivotal Clinical Trial for Alzheimer’s Disease based on Transcranial Photobiomodulation. Vielight Commences Pivotal Clinical Trial for Alzheimer’s Disease based on Transcranial Photobiomodulation. RecommendedINVENTURE$ 2023 draws to a close with record numbers in attendanceLargest Estuary Restoration Project on Vancouver Island starts work to revitalize crucial estuarine habitatCall2Recycle Canada, already a leader in operational excellence, raises the bar with ISO 9001 certification
